Compass Therapeutics, Inc. [•] Shares1 Common Stock ($0.0001 par value) Underwriting AgreementUnderwriting Agreement • November 9th, 2020 • Compass Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 9th, 2020 Company Industry Jurisdiction